Atlas Trials

Extended Study of RAG-17 in the Treatment of Amyotrophic Lateral Sclerosis Patients With SOD1 Gene Mutation

Clinical trial NCT07077668 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07077668
Sponsor
Beijing Tiantan Hospital
Status
NOT_YET_RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
ALS (Amyotrophic Lateral Sclerosis)
Start date
2025-07-01
Primary completion
2026-12-31
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.